To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
Clinical trial NCT01284348 · TERMINATED
Trial details
- NCT number
- NCT01284348
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-25
- Primary completion
- 2012-09-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.